Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
19
pubmed:dateCreated
2005-5-17
pubmed:abstractText
Postprandial hypertriglyceridemia and hyperglycemia are considered risk factors for cardiovascular disease. Evidence suggests that postprandial hypertriglyceridemia and hyperglycemia induce endothelial dysfunction and inflammation through oxidative stress. Statins and angiotensin type 1 receptor blockers have been shown to reduce oxidative stress and inflammation, improving endothelial function.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1524-4539
pubmed:author
pubmed:issnType
Electronic
pubmed:day
17
pubmed:volume
111
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2518-24
pubmed:meshHeading
pubmed-meshheading:15867169-Anticholesteremic Agents, pubmed-meshheading:15867169-Biphenyl Compounds, pubmed-meshheading:15867169-Case-Control Studies, pubmed-meshheading:15867169-Diabetes Mellitus, Type 2, pubmed-meshheading:15867169-Drug Therapy, Combination, pubmed-meshheading:15867169-Endothelium, Vascular, pubmed-meshheading:15867169-Female, pubmed-meshheading:15867169-Heptanoic Acids, pubmed-meshheading:15867169-Humans, pubmed-meshheading:15867169-Hyperglycemia, pubmed-meshheading:15867169-Hypertriglyceridemia, pubmed-meshheading:15867169-Inflammation, pubmed-meshheading:15867169-Male, pubmed-meshheading:15867169-Middle Aged, pubmed-meshheading:15867169-Oxidative Stress, pubmed-meshheading:15867169-Postprandial Period, pubmed-meshheading:15867169-Pyrroles, pubmed-meshheading:15867169-Tetrazoles, pubmed-meshheading:15867169-Treatment Outcome
pubmed:year
2005
pubmed:articleTitle
Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients.
pubmed:affiliation
Department of Pathology and Medicine, Experimental and Clinical, Chair of Internal Medicine, University of Udine, Udine, Italy. ceriello@uniud.it
pubmed:publicationType
Journal Article, Controlled Clinical Trial